Order Article Reprints

Gingele S, Jacobus TL, Konen FF, Hümmert MW, Sühs K-W, Schwenkenbecher P, Ahlbrecht J, Möhn N, Müschen LH, Bönig L, et al. Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients. Cells. 2019; 8(1):12. https://doi.org/10.3390/cells8010012

Gingele, Stefan, Thais Langer Jacobus, Franz Felix Konen, Martin W. Hümmert, Kurt-Wolfram Sühs, Philipp Schwenkenbecher, Jonas Ahlbrecht, Nora Möhn, Lars H. Müschen, Lena Bönig, and et al. 2019. "Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients" Cells 8, no. 1: 12. https://doi.org/10.3390/cells8010012

Gingele, S., Jacobus, T. L., Konen, F. F., Hümmert, M. W., Sühs, K.-W., Schwenkenbecher, P., Ahlbrecht, J., Möhn, N., Müschen, L. H., Bönig, L., Alvermann, S., Schmidt, R. E., Stangel, M., Jacobs, R., & Skripuletz, T. (2019). Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients. Cells, 8(1), 12. https://doi.org/10.3390/cells8010012